Literature DB >> 32950484

Hypoglycemia increases endothelial-dependent vasodilation through suppressing phosphorylation at Threonine 495/497 site of endothelial nitric oxide synthase.

An He1, Deyu Zuo1, Xiaoxue Liang1, Yongzheng Guo1, Luo Suxin2, Yong Xia3.   

Abstract

OBJECTIVE: Phosphorylation plays an essential role in the regulation of endothelial nitric oxide synthase (eNOS) activity. However, the phosphorylation of eNOS under hypoglycemia and whether hypoglycemia changes eNOS activity is unknown. This paper aims to clarify the regulation of eNOS phosphorylation and its activity change under hypoglycemia.
METHODS: Bovine aortic endothelial cells (BAECs) and Sprague-Dawley rats were treated with hypoglycemia, and the phosphorylation of eNOS was subjected to western blot. Blood nitric oxide (NO) concentration was determined by NO kit and endothelial-dependent vasodilation was detected by multi-wire myograph.
RESULTS: In both BAECs and rats' thoracic aorta, hypoglycemia induced eNOS phosphorylation decrease specifically on Threonine (Thr) 497. Inhibition of ubiquitination of protein kinase C α subunit (PKCα) reverses the decrease of eNOS phosphorylation in hypoglycemia. Ubiquitinated PKCα can be reversed by AMPK knockdown. In rats, insulin induced hypoglycemia increased the concentration of NO in arterial blood, and progressively enhanced the endothelium-dependent vasodilation of the thoracic and mesenteric aorta.
CONCLUSIONS: In vitro, the activation of AMPK may lead to the expression of PKCα by regulating ubiquitination, resulting in a decrease in the level of P-eNOS Thr497 phosphorylation under hypoglycemia. In vivo, insulin-induced hypoglycemia produces a beneficial cardiovascular effect on rats.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Endothelium-dependent vasodilation; Hypoglycemia; eNOS phosphorylation

Year:  2020        PMID: 32950484     DOI: 10.1016/j.mvr.2020.104075

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  3 in total

Review 1.  Old and Novel Therapeutic Approaches in the Management of Hyperglycemia, an Important Risk Factor for Atherosclerosis.

Authors:  Milijana Janjusevic; Alessandra Lucia Fluca; Giulia Gagno; Alessandro Pierri; Laura Padoan; Annamaria Sorrentino; Antonio Paolo Beltrami; Gianfranco Sinagra; Aneta Aleksova
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

2.  Naringenin ameliorates homocysteine induced endothelial damage via the AMPKα/Sirt1 pathway.

Authors:  Hui Li; Linlin Liu; Zhiwen Cao; Wen Li; Rui Liu; Youwen Chen; Chenxi Li; Yurong Song; Guangzhi Liu; Jinghong Hu; Zhenli Liu; Cheng Lu; Yuanyan Liu
Journal:  J Adv Res       Date:  2021-01-23       Impact factor: 10.479

3.  Recurrent Hypoglycemia Impaired Vascular Function in Advanced T2DM Rats by Inducing Pyroptosis.

Authors:  Minghao Luo; Yu Hu; Dingyi Lv; Lingyun Xie; Shenglan Yang; Deyu Zuo; Yuzhou Xue; An He
Journal:  Oxid Med Cell Longev       Date:  2022-07-23       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.